SAN DIEGO--(BUSINESS WIRE)--Apr. 18, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps available in the
United States, plans to release its first quarter 2018 results after the
financial markets close on Thursday, April 26, 2018. The Company will
hold a conference call and simultaneous webcast on the same day at 4:30
p.m. Eastern Time (1:30 p.m. Pacific Time), to discuss its first quarter
2018 financial and operating results.
Conference Call/Webcast Details:
April 26, 2018
Time:4:30 p.m. Eastern Time (1:30 p.m.
Toll Free Dial-In Number: (855) 427-4396
Dial-In Number: (484) 756-4261
Conference ID: 8129808
An archive of the webcast will be available for 30 days following the
event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump, the only pump capable of remote feature updates using
a personal computer, now available with Dexcom G5® Mobile continuous
glucose monitoring (CGM) integration, and the t:flex® Insulin Pump, the
first pump designed for people with greater insulin requirements. Tandem
is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2,
#tflex, #tconnect, and $TNDM.
Follow Tandem Diabetes Care on
Facebook at www.facebook.com/TandemDiabetes.
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
t:flex and Tandem Diabetes Care are registered trademarks, and t:slim X2
is a trademark of Tandem Diabetes Care, Inc. Dexcom G5 is a registered
trademark of Dexcom, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180418005909/en/
Source: Tandem Diabetes Care, Inc.
For Tandem Diabetes Care, Inc.